| Name | Title | Contact Details |
|---|
The NCH Healthcare System is a not-for-profit multi-facility healthcare system located in Naples, Florida. The system includes two hospitals (NCH Healthcare System – Downtown Naples Hospital and NCH Healthcare System – North Naples Hospital) with a total of 681 beds collaborating with 630 physicians to care for more than 32,000 patients each year. Outpatient facilities include Walk-in Centers, Wellness Centers, Rehabilitation Centers, Wound Care Facilities, and Infusion Centers in Naples, North Naples, Marco Island, Bonita Springs, and Estero. NCH`s Emergency Departments and outpatient facilities had over 120,000 visits for the past two years. Caring for all ages in the communities it serves, NCH performs almost 500 open heart surgeries and 3,400 newborn deliveries each year.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Biomed Pharmaceuticals is a Sharon Hill, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Indiana Hemophilia & Thrombosis Center (IHTC) is the only federally recognized comprehensive hemophilia treatment center in Indiana and one of the largest centers in the nation. The IHTC is a 501(c)3 nonprofit entity that is dedicated to providing the best, most comprehensive care to people in Indiana with bleeding or clotting disorders and to their families. The IHTC is both nationally and internationally distinguished as a Center of Excellence for its leadership in bleeding disorder patient care, education and research.
Applied Reimbursement Techniques is a Mobile, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.